BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2348779)

  • 1. Comparative activity of human and murine tumor necrosis factor in toxicity and anti-infectious assays in mice.
    Parant F; Tavernier J; Fiers W; Parant M
    Microb Pathog; 1990 Feb; 8(2):143-9. PubMed ID: 2348779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of endogenous glucocorticoid on endotoxin-induced production of circulating TNF-alpha.
    Parant M; Le Contel C; Parant F; Chedid L
    Lymphokine Cytokine Res; 1991 Aug; 10(4):265-71. PubMed ID: 1932370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Protective effect of tumor necrosis factor (TNF) obtained by genetic recombination against experimental bacterial or fungal infection].
    Parant M; Parant F; Vinit MA; Chedid L
    C R Acad Sci III; 1987; 304(1):1-4. PubMed ID: 3099988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice.
    Lehmann V; Freudenberg MA; Galanos C
    J Exp Med; 1987 Mar; 165(3):657-63. PubMed ID: 3819645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-1 alpha enhances hepatotoxicity of tumor necrosis factor-alpha in galactosamine-sensitized mice.
    Nagakawa J; Hishinuma I; Hirota K; Miyamoto K; Yasuda M; Yamanaka T; Katayama K
    Immunopharmacol Immunotoxicol; 1991; 13(4):485-98. PubMed ID: 1774433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel recombinant tumor necrosis factor-alpha mutant with increased anti-tumor activity and lower toxicity.
    Nakamura S; Kato A; Masegi T; Fukuoka M; Kitai K; Ogawa H; Ichikawa Y; Maeda M; Watanabe N; Kohgo Y
    Int J Cancer; 1991 Jul; 48(5):744-8. PubMed ID: 1649139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multistep regulation mechanisms for tolerance induction to lipopolysaccharide lethality in the tumor-necrosis-factor-alpha-mediated pathway. Application of non-toxic monosaccharide lipid A analogues for elucidation of mechanisms.
    Matsuura M; Kiso M; Hasegawa A; Nakano M
    Eur J Biochem; 1994 Apr; 221(1):335-41. PubMed ID: 8168521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopolysaccharide (LPS)-induced intra-uterine fetal death (IUFD) in mice is principally due to maternal cause but not fetal sensitivity to LPS.
    Kohmura Y; Kirikae T; Kirikae F; Nakano M; Sato I
    Microbiol Immunol; 2000; 44(11):897-904. PubMed ID: 11145270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukocyte alterations do not account for hepatitis induced by endotoxin or TNF alpha in galactosamine-sensitized mice.
    Tiegs G; Niehörster M; Wendel A
    Biochem Pharmacol; 1990 Sep; 40(6):1317-22. PubMed ID: 2403385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum protease inhibitor abrogation of Newcastle disease virus enhancement of cytolysis by recombinant tumor necrosis factors alpha and beta.
    Rood PA; Lorence RM; Kelley KW
    J Natl Cancer Inst; 1990 Feb; 82(3):213-7. PubMed ID: 2296051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor and interleukin-1 protection against the lethal effects of tumor necrosis factor.
    Sheppard BC; Norton JA
    Surgery; 1991 Jun; 109(6):698-705. PubMed ID: 2042087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective species specificity of tumor necrosis factor for toxicity in the mouse.
    Brouckaert P; Libert C; Everaerdt B; Fiers W
    Lymphokine Cytokine Res; 1992 Aug; 11(4):193-6. PubMed ID: 1420597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does high mobility group 1 protein function as a late mediator for LPS- or TNF-induced shock in galactosamine-sensitized mice?
    Hasunuma R; Maruyama H; Takimoto H; Ryll R; Tanaka S; Kumazawa Y
    J Endotoxin Res; 2002; 8(5):391-8. PubMed ID: 12537698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipopolysaccharide-induced fetal death: the role of tumor-necrosis factor alpha.
    Silver RM; Lohner WS; Daynes RA; Mitchell MD; Branch DW
    Biol Reprod; 1994 May; 50(5):1108-12. PubMed ID: 8025168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid-dependent and -independent mechanisms involved in lipopolysaccharide tolerance.
    Evans GF; Zuckerman SH
    Eur J Immunol; 1991 Sep; 21(9):1973-9. PubMed ID: 1716205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced susceptibility of nonobese diabetic mice to TNF-alpha and D-galactosamine-mediated hepatocellular apoptosis and lethality.
    Bahjat FR; Dharnidharka VR; Fukuzuka K; Morel L; Crawford JM; Clare-Salzler MJ; Moldawer LL
    J Immunol; 2000 Dec; 165(11):6559-67. PubMed ID: 11086099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The glucocorticoid antagonist RU38486 mimics interleukin-1 in its sensitization to the lethal and interleukin-6-inducing properties of tumor necrosis factor.
    Brouckaert P; Everaerdt B; Fiers W
    Eur J Immunol; 1992 Apr; 22(4):981-6. PubMed ID: 1532365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of interleukin-10 at the time of priming protects Corynebacterium parvum-primed mice against LPS- and TNF-alpha-induced lethality.
    Smith SR; Terminelli C; Denhardt G; Narula S; Thorbecke GJ
    Cell Immunol; 1996 Nov; 173(2):207-14. PubMed ID: 8912878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation.
    Sekut L; Yarnall D; Stimpson SA; Noel LS; Bateman-Fite R; Clark RL; Brackeen MF; Menius JA; Connolly KM
    Clin Exp Immunol; 1995 Apr; 100(1):126-32. PubMed ID: 7697910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipopolysaccharide (LPS)-induced cell death of C3H mouse peritoneal macrophages in the presence of cycloheximide: different susceptibilities of C3H/HeN and C3H/HeJ mice macrophages.
    Karahashi H; Amano F
    J Endotoxin Res; 2000; 6(1):33-9. PubMed ID: 11061030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.